Biocon bags sixth place in Global Biotech Employers ranking for 2019

Published On 2019-10-29 06:00 GMT   |   Update On 2019-10-29 06:00 GMT

Kiran Mazumdar Shaw, CMD, Biocon said: "We have consciously created a culture that encourages ideation, experimentation and collaboration to address unmet patient needs."


Bengaluru: Bengaluru-headquartered biopharmaceuticals company Biocon Ltd has moved up to the sixth spot in the Top 10 Global Biotech Employers ranking for 2019.


It continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 20 Employers' list, since its debut in 2012.


Ranked at number six among global pharma and biotech companies in 2019, Biocon has moved up from number seven in 2018 and number nine in 2017.


Biocon said in a statement it has been consistently recognised for three key attributes: "Innovative leader in the industry, 'is socially responsible' and leadership makes changes needed."


The ranking is a result of the 2019 Science Careers Top Employers global survey conducted by the US-based Science magazine to determine which companies in the biotech and pharmaceutical industry have the best reputations as employers globally.


Also Read: Biocon arm signs licensing agreement with Evotec for biosimilar asset


Kiran Mazumdar Shaw, CMD, Biocon said: "We have consciously created a culture that encourages ideation, experimentation and collaboration to address unmet patient needs."


Biocon was ahead of leading global pharma companies like Novozymes, Roche, Eli Lilly, Abbott, Novartis, Pfizer etc. in the 2019 rankings.


The Top 5 global players in this year's list are Alnylam, Regeneron, Incyte, Merck KGaA and Spark therapeutics.


Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including 'innovative leader in the industry,' 'treating employees with respect,' 'is socially responsible,' 'work culture values aligned' and 'leadership makes changes needed,' it was stated.


Also Read: Biocon, Mylan launch insulin biosimilar Semglee in Australia

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News